Abstract
Objective: To assess if patients treated with omega-3(n-3) polyunsaturated fatty acids (PUFAS) had lower procedural failure rates compared to an untreated population. Methods and Results: From January 2004 to 2007, 1500 PVAI patients underwent catheter ablation. Two hundred and eighty five (19%) patients were treated with PUFAs. These patients were matched in a nested case controlled analysis. After matching, there were 129 patients in the PUFA group and 129 in the control group. Thirty-five (27.1%) patients in the study group had early recurrence vs. 57 (44.1%) in the control group p-value<0.0001. Twenty-nine (23.2%) patients in the PUFA group vs. 41 (31.7%) in the non-PUFA group had procedural failure (p-value <0.003). There were no significant differences in complications in the PUFA and non-PUFA groups. Conclusion: Patients treated with PUFAs had lower incidences of early recurrence and procedural failure compared to an untreated population.
Original language | English (US) |
---|---|
Pages (from-to) | 292-298 |
Number of pages | 7 |
Journal | Indian Pacing and Electrophysiology Journal |
Volume | 9 |
Issue number | 6 |
State | Published - 2009 |
Externally published | Yes |
Keywords
- Atrial Fibrillation (AF)
- Polyunsaturated Fatty acids (PUFA)
- Pulmonary vein isolation (PVAI)
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Physiology (medical)